Mounjaro
Tirzepatide · Eli Lilly
Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that works on two incretin hormones simultaneously. It has shown even greater weight loss than semaglutide in clinical trials — up to 22.5% body weight.
FDA-Approved Uses
Mounjaro is FDA-approved for the following conditions.
Dosing: 2.5mg escalating to 15mg weekly injection
Average Cost
What you can expect to pay for Mounjaro.
Need help affording Mounjaro?
Answer 9 questions. See every program you're eligible for. Free.
Medicaid Coverage by State
Mounjaro coverage status across all 51 states and territories.
| State | Medicaid | Medicare | Prior Auth |
|---|---|---|---|
| Alabama | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Alaska | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Arizona | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Arkansas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| California | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Colorado | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Connecticut | Covered | Covered (Prior Auth) | No |
| Delaware | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| District of Columbia | Covered | Covered (Prior Auth) | No |
| Florida | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Georgia | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Hawaii | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Idaho | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Illinois | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Indiana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Iowa | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Kansas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Kentucky | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Louisiana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Maine | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Maryland | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Massachusetts | Covered | Covered (Prior Auth) | No |
| Michigan | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Minnesota | Covered | Covered (Prior Auth) | No |
| Mississippi | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Missouri | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Montana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Nebraska | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Nevada | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Hampshire | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Jersey | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Mexico | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New York | Covered | Covered (Prior Auth) | No |
| North Carolina | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| North Dakota | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Ohio | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Oklahoma | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Oregon | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Pennsylvania | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Rhode Island | Covered | Covered (Prior Auth) | No |
| South Carolina | Covered (Prior Auth) | Covered (Prior Auth) | No |
| South Dakota | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Tennessee | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Texas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Utah | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Vermont | Covered | Covered (Prior Auth) | No |
| Virginia | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Washington | Covered | Covered (Prior Auth) | No |
| West Virginia | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Wisconsin | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Wyoming | Covered (Prior Auth) | Covered (Prior Auth) | No |
Patient Assistance Programs
Eli Lilly offers savings programs that may reduce your cost to $0. Check eligibility below.
Check Eligibility at Eli Lilly ↗Mounjaro Side Effects
Common and serious side effects to discuss with your doctor.
⚡ Common Side Effects
- Nauseacommon
- Diarrheacommon
- Decreased appetitecommon
- Vomitingcommon
- Constipationcommon
⚠️ Serious Side Effects
- Pancreatitisrare
- Thyroid tumorsrare
Seek immediate medical attention if you experience any serious side effects.
Monitor Side Effects
Track Mounjaro Side Effects with Helix
Oura-style monitoring for your Mounjaro journey. Log side effects, see trends over time, and share reports with your doctor.
Try Helix Free →Free side effect tracking
Track Your Mounjaro Journey
Meet Enzo — Your GLP-1 Companion
A virtual pet that grows as you track your Mounjaro doses, weight, and meals. Stay motivated with streaks, milestones, and a buddy who celebrates your progress.
Try Enzo Free →Free on iOS and Android
Frequently Asked Questions
How much does Mounjaro cost without insurance?
Mounjaro costs approximately $1,023 per month without insurance. With insurance, copays range from $25 to $150 per month.
Does Medicaid cover Mounjaro?
Medicaid coverage for Mounjaro varies by state. Many states cover it with prior authorization. See the coverage table below for your state.
What are the side effects of Mounjaro?
Common side effects include nausea, diarrhea, decreased appetite. Serious but rare side effects include pancreatitis and thyroid tumors.
What is the generic name for Mounjaro?
The generic name for Mounjaro is Tirzepatide. It is manufactured by Eli Lilly.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.
Compare Mounjaro
Mounjaro's dual GIP/GLP-1 mechanism may produce greater weight loss than Ozempic's GLP-1-only approach.
Mounjaro vs ZepboundSame active ingredient (tirzepatide) but different FDA approvals: Mounjaro for diabetes, Zepbound for weight management.
Mounjaro vs TrulicityBoth made by Eli Lilly. Mounjaro's dual GIP/GLP-1 mechanism shows superior A1C and weight outcomes vs Trulicity.
Other GLP-1 Medications
Weekly GLP-1 injection for type 2 diabetes and weight management
WegovyFDA-approved weekly injection for chronic weight management
ZepboundFDA-approved dual-action injection for chronic weight management
SaxendaDaily GLP-1 injection for weight management
RybelsusFirst oral GLP-1 tablet for type 2 diabetes
TrulicityWeekly GLP-1 injection for type 2 diabetes
VictozaDaily GLP-1 injection for type 2 diabetes